Latest Interviews
Showing 1–3 of 3 transcripts.
Clear all filters- a16z59 min
a16z Podcast | The Science and Business of Innovative Medicines
Jorge Conde, Vijay Pande, Sonal Chokshi, Vas Narasimhan
Novartis transformed its portfolio through a $50 billion restructuring that divested consumer healthcare to prioritize advanced therapies, data science, and proprietary platforms for cell and gene treatments. Under CEO Vas Narasimhan, the company enforces strict "standard of care" mandates for project approval, integrates market access early in development, and invested $15 billion to own specialized infrastructure while leveraging AI for financial forecasting and pathology analysis. This strategic pivot targets a 10% clinical success rate by shifting from bespoke drug development to modular platforms and dedicated digital innovation centers, positioning the firm to address undruggable targets and future modalities like xenotransplantation.
- a16z33 min
a16z Podcast | Building Crypto, from Vision to Reality
Brian Armstrong, Chris Dixon, Sonal Chokshi
Coinbase founder Brian Armstrong outlines a roadmap for transforming cryptocurrency from a speculative asset class into a functional utility phase by addressing critical infrastructure gaps in scalability, wallet usability, and fiat on-ramps. The industry is leveraging stablecoins and decentralized autonomous organizations like MakerDAO to mitigate volatility and enable programmable money, while predicting that an open financial system serving one billion users could emerge within five years. Concurrently, the ecosystem is fostering combinatorial innovation through reusable protocols and NFTs, aiming to displace traditional ad-based revenue models with transaction-based economies supported by regulated institutional infrastructure.
- a16z33 min
a16z Podcast | The Regulatory Landscape for Crypto
Katie Haun, Robin Weisman, Sonal Chokshi
U.S. federal agencies including the SEC, CFTC, and DOJ clarify that while Bitcoin's underlying technology is legal, specific applications like exchanges and ICOs remain subject to existing financial regulations enforced through distinct civil and criminal pathways. Recent policy shifts demonstrate a move toward differentiating utility tokens from securities based on network decentralization while maintaining extraterritorial jurisdiction over firms serving U.S. customers. Consequently, regulators coordinate efforts to target fraud and illicit activity rather than innovation, advising enterprises to demonstrate good-faith compliance to mitigate enforcement risks.